,"Author: Clark, Andrew R.",,,,,,,,,,,
,,,,,,,,,,,,
,"h index = 23 (Of the 39 documents considered for the h-Index, 23 have been cited at least 23 times.)",,,,,,,,,,,
,Note: The h Index considers Scopus documents published after 1995.  ,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,<2007,2007,2008,subtotal,>2008,total
Publication Year,Document Title,Authors,ISSN,Journal Title,Volume,Issue,2265,405,394,799,197,3261
2009,"The p38 MAPK pathway inhibits tristetraprolin-directed decay of interleukin-10 and pro-inflammatory mediator mRNAs in murine macrophages","Tudor C., Dean J.L.E., Marchese F.P., Hitti E., Aubareda A., Rawlinson L., Gaestel M., Blackshear P.J., Clark A.R., Saklatvala J.",00145793,"FEBS Letters",583, 12,0,0,0,0,0,0
2009,"Post-transcriptional gene regulation by MAP kinases via AU-rich elements.","Clark A., Dean J., Tudor C., Saklatvala J.",10934715,"Frontiers in bioscience : a journal and virtual library",14, ,0,0,0,0,1,1
2008,"Increased endothelial mitogen-activated protein kinase phosphatase-1 expression suppresses proinflammatory activation at sites that are resistant to atherosclerosis.","Zakkar M., Haskard D.O., Evans P.C., Chaudhury H., Sandvik G., Enesa K., Luong A., Cuhlmann S., Mason J.C., Krams R., Clark A.R.",15244571,"Circulation research",103, 7,0,0,0,0,4,4
2008,"Role of dual specificity phosphatases in biological responses to glucocorticoids","Clark A.R., Martins J.R.S., Tchen C.R.",00219258,"Journal of Biological Chemistry",283, 38,0,0,0,0,1,1
2008,"A comparison of the pulmonary bioavailability of powder and liquid aerosol formulations of salmon calcitonin","Clark A., Kuo M.-C., Newman S., Hirst P., Pitcairn G., Pickford M.",07248741,"Pharmaceutical Research",25, 7,0,0,0,0,0,0
2007,"Anti-inflammatory functions of glucocorticoid-induced genes","Clark A.R.",03037207,"Molecular and Cellular Endocrinology",275, 1-2,0,1,15,16,11,27
2007,"Design of fine particles for pulmonary drug delivery","Weers J.G., Tarara T.E., Clark A.R.",17425247,"Expert Opinion on Drug Delivery",4, 3,0,1,4,5,0,5
2007,"The effect of biphasic inhalation profiles on the deposition and clearance of coarse (6.5 ?m) bolus aerosols","Clark A.R., Chambers C.B., Muir D., Newhouse M.T., Paboojian S., Schuler C.",08942684,"Journal of Aerosol Medicine: Deposition, Clearance, and Effects in the Lung",20, 1,0,0,4,4,1,5
2006,"The RNA binding protein Zfp36l1 is required for normal vascularisation and post-transcriptionally regulates VEGF expression","Bell S.E., Turner M., Sanchez M.J., Spasic-Boskovic O., Santalucia T., Gambardella L., Burton G.J., Murphy J.J., Norton J.D., Clark A.R.",10588388,"Developmental Dynamics",235, 11,0,1,4,5,2,7
2006,"Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1","Abraham S.M., Lawrence T., Kleiman A., Warden P., Medghalchi M., Tuckermann J., Saklatvala J., Clark A.R.",00221007,"Journal of Experimental Medicine",203, 8,2,20,25,45,12,59
2006,"Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine/uridine-rich element","Hitti E., Gaestel M., Iakovleva T., Brook M., Deppenmeier S., Gruber A.D., Radzioch D., Clark A.R., Blackshear P.J., Kotlyarov A.",02707306,"Molecular and Cellular Biology",26, 6,5,30,28,58,20,83
2006,"Posttranslational regulation of tristetraprolin subcellular localization and protein stability by p38 mitogen-activated protein kinase and extracellular signal-regulated kinase pathways","Brook M., Tchen C.R., Santalucia T., McIlrath J., Arthur J.S.C., Saklatvala J., Clark A.R.",02707306,"Molecular and Cellular Biology",26, 6,3,17,19,36,13,52
2005,"Erratum: The 3? untranslated region of tumor necrosis factor alpha mRNA is a target of the mRNA-stabilizing factor HuR (Molecular and Cellular Biology (2001) 21:3 (721-730))","Dean J.L.E., Wait R., Mahtani K.R., Sully G., Clark A.R., Saklatvala J.",02707306,"Molecular and Cellular Biology",25, 8,0,0,0,0,0,0
2005,"Stabilization of IFN-? mRNA by MAPK p38 in IL-12- and IL-18-stimulated human NK cells","Mavropoulos A., Sully G., Cope A.P., Clark A.R.",00064971,"Blood",105, 1,10,6,4,10,3,23
2004,"The involvement of AU-rich element-binding proteins in p38 mitogen-activated protein kinase pathway-mediated mRNA stabilisation","Dean J.L.E., Sully G., Clark A.R., Saklatvala J.",08986568,"Cellular Signalling",16, 10,48,41,33,74,12,134
2004,"The stability of tristetraprolin mRNA is regulated by mitogen-activated protein kinase p38 and by tristetraprolin itself","Tchen C.R., Brook M., Saklatvala J., Clark A.R.",00219258,"Journal of Biological Chemistry",279, 31,19,9,8,17,6,42
2004,"Physical Stability of Salmon Calcitonin Spray-Dried Powders for Inhalation","Chan H.-K., Clark A.R., Feeley J.C., Kuo M.-C., Lehrman S.R., Pikal-Cleland K., Miller D.P., Vehring R., Lechuga-Ballesteros D.",00223549,"Journal of Pharmaceutical Sciences",93, 3,7,8,10,18,4,29
2004,"Structural and functional dissection of a conserved destabilizing element of cyclo-oxygenase-2 mRNA: Evidence against the involvement of AUF-1 [AU-rich element/poly(U)-binding/degradation factor-1], AUF-2, tristetraprolin, HuR (Hu antigen R) or FBP1 (far-upstream-sequence-element-binding protein 1)","Sully G., Dean J.L.E., Wait R., Rawlinson L., Santalucia T., Saklatvala J., Clark A.R.",02646021,"Biochemical Journal",377, 3,9,12,8,20,2,31
2003,"Control of the expression of inflammatory response genes","Saklatvala J., Dean J., Clark A.",00678694,"Biochemical Society Symposium",, 70,19,5,8,13,6,38
2003,"Crosstalk between glucocorticoids and mitogen-activated protein kinase signalling pathways","Clark A.R., Lasa M.",14714892,"Current Opinion in Pharmacology",3, 4,20,12,8,20,3,43
2003,"Post-transcriptional regulation of gene expression by mitogen-activated protein kinase p38","Clark A.R., Dean J.L.E., Saklatvala J.",00145793,"FEBS Letters",546, 1,58,15,10,25,5,88
2003,"Inhalation of a dry powder tobramycin pulmosphere formulation in healthy volunteers","Newhouse M.T., Hirst P.H., Duddu S.P., Walter Y.H., Tarara T.E., Clark A.R., Weers J.G.",00123692,"Chest",124, 1,17,7,12,19,3,39
2003,"MAP kinase phosphatase 1: A novel mediator of biological effects of glucocorticoids?","Clark A.R.",00220795,"Journal of Endocrinology",178, 1,28,10,7,17,4,49
2002,"Dexamethasone causes sustained expression of mitogen-activated protein kinase (MAPK) phosphatase 1 and phosphatase-mediated inhibition of MAPK p38","Lasa M., Abraham S.M., Boucheron C., Saklatvala J., Clark A.R.",02707306,"Molecular and Cellular Biology",22, 22,87,31,32,63,12,162
2002,"Identification of a novel AU-rich-element-binding protein which is related to AUF1","Dean J.L.E., Sully G., Wait R., Rawlinson L., Clark A.R., Saklatvala J.",02646021,"Biochemical Journal",366, 3,22,2,2,4,1,27
2001,"Mitogen-activated protein kinase p38 controls the expression and posttranslational modification of tristetraprolin, a regulator of tumor necrosis factor alpha mRNA stability","Mahtani K.R., Brook M., Dean J.L.E., Sully G., Saklatvala J., Clark A.R.",02707306,"Molecular and Cellular Biology",21, 19,122,20,26,46,11,179
2001,"Dexamethasone destabilizes cyclooxygenase 2 mRNA by inhibiting mitogen-activated protein kinase p38","Lasa M., Brook M., Saklatvala J., Clark A.R.",02707306,"Molecular and Cellular Biology",21, 3,100,15,7,22,9,131
2001,"The 3? Untranslated region of tumor necrosis factor alpha mRNA is a target of the mRNA-stabilizing factor HuR","Dean J.L.E., Wait R., Mahtani K.R., Sully G., Clark A.R., Saklatvala J.",02707306,"Molecular and Cellular Biology",21, 3,106,12,14,26,2,134
2000,"Regulation of tumour necrosis factor ? mRNA stability by the mitogen-activated protein kinase p38 signalling cascade","Brook M., Sully G., Clark A.R., Saklatvala J.",00145793,"FEBS Letters",483, 1,102,9,13,22,2,126
2000,"Regulation of cyclooxygenase 2 mRNA stability by the mitogen- activated protein kinase p38 signaling cascade","Lasa M., Mahtani K.R., Finch A., Brewer G., Saklatvala J., Clark A.R.",02707306,"Molecular and Cellular Biology",20, 12,189,26,21,47,14,250
1999,"Inhale's dry-powder pulmonary drug delivery system: Challenges to current modeling of gas-solid flows","Bakshi A., Tuttle D., Smith A., Paboojian S., Snyder H., Schuler C., Rasmussen D., Clark A.",,"Proceedings of the 1999 3rd ASME/JSME Joint Fluids Engineering Conference, FEDSM'99, San Francisco, California, USA, 18-23 July 1999 (CD-ROM)",, ,0,0,0,0,0,0
1999,"p38 Mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes","Dean J.L.E., Brook M., Clark A.R., Saklatvala J.",00219258,"Journal of Biological Chemistry",274, 1,271,30,18,48,8,327
1998,"A p38 MAP kinase inhibitor regulates stability of interleukin-1-induced cyclooxygenase-2 mRNA","Ridley S.H., Dean J.L.E., Sarsfield S.J., Brook M., Clark A.R., Saklatvala J.",00145793,"FEBS Letters",439, 1-2,130,16,7,23,2,155
1998,"Inspiratory flow rate and dynamic lung function in cystic fibrosis and chronic obstructive lung diseases","Sarinas P.S.A., Robinson T.E., Clark A.R., Canfield Jr. J., Chitkara R.K., Fick Jr. R.B.",00123692,"Chest",114, 4,7,4,2,6,0,13
1998,"New aerosol delivery systems for cystic fibrosis","Clark A.",87556863,"Pediatric Pulmonology",26, 3,1,0,0,0,0,1
1998,"Effect of smaller droplet size of dornase alfa on lung function in mild cystic fibrosis","Geller D.E., Eigen H., Fiel S.B., Clark A., Lamarre A.P., Johnson C.A., Konstan M.W.",87556863,"Pediatric Pulmonology",25, 2,16,1,2,3,2,21
1997,"A new method for bronchial-provocation testing in asthmatic subjects using a dry powder of mannitol","Anderson S.D., Brannan J., Spring J., Spalding N., Rodwell L.T., Chan K., Gonda I., Walsh A., Clark A.R.",1073449X,"American Journal of Respiratory and Critical Care Medicine",156, 3 I,54,8,7,15,7,76
1996,"MDIs: Physics of aerosol formation","Clark A.R.",08942684,"Journal of Aerosol Medicine: Deposition, Clearance, and Effects in the Lung",9, 1,14,3,1,4,1,19
1996,"The pulmonary deposition of two aerosol preparations of nedocromil sodium delivered by MDI assessed by single photon emission computed tomography","Summers Q.A., Holgate S.T., Fleming J.S., Dai Y., Perring S., Honeywell R., Gough K.J., Renwick A.G., Clark A.R., Nassim M.A.",08942684,"Journal of Aerosol Medicine: Deposition, Clearance, and Effects in the Lung",9, 1,11,0,1,1,0,12
1995,"A silencer and an adjacent positive element interact to modulate the activity of the human insulin promoter","Clark A.R., Wilson M.E., Leibiger I., Scott V., Docherty K.",00142956,"European Journal of Biochemistry",232, 2,11,0,0,0,1,12
1995,"The use of laser diffraction for the evaluation of the aerosol clouds generated by medical nebulizers","Clark A.R.",03785173,"International Journal of Pharmaceutics",115, 1,59,6,2,8,2,69
1995,"Identification and characterization of a functional retinoic acid/thyroid hormone-response element upstream of the human insulin gene enhancer","Clark A.R., Wilson M.E., London N.J.M., James R.F.L., Docherty K.",02646021,"Biochemical Journal",309, 3,18,1,2,3,0,21
1995,"Medical aerosol inhalers: Past, present, and future","Clark A.R.",02786826,"Aerosol Science and Technology",22, 4,54,4,4,8,1,63
1994,"Nutrient regulation of insulin gene expression","Docherty K., Clark A.R.",08926638,"FASEB Journal",8, 1,83,2,5,7,0,90
1994,"Effect of different modes of inhalation on drug delivery from a dry powder inhaler","Newman S.P., Hollingworth A., Clark A.R.",03785173,"International Journal of Pharmaceutics",102, 1-3,78,3,6,9,2,89
1994,"The gel retardation assay.","Scott V., Clark A.R., Docherty K.",10643745,"Methods in molecular biology (Clifton, N.J.)",31, ,7,0,0,0,0,7
1994,"Modelling the deposition of inhaled powdered drug aerosols","Clark A.R., Egan M.",00218502,"Journal of Aerosol Science",25, 1,23,1,0,1,0,24
1994,"Assessment of aerosol delivery systems for recombinant human deoxyribonuclease","Cipolla D.C., Clark A.R., Chan H.-K., Gonda I., Shire S.J.",11571489,"S.T.P. Pharma Sciences",4, 1,51,0,3,3,1,55
1993,"Negative regulation of transcription in eukaryotes","Clark A.R., Docherty K.",02646021,"Biochemical Journal",296, 3,54,0,0,0,0,54
1993,"Human insulin gene enhancer-binding proteins in pancreatic ? and ? cell lines","Clark A.R., Petersen H.V., Read M.L., Scott V., Michelsen B.K., Docherty K.",00145793,"FEBS Letters",329, 1-2,10,0,1,1,0,11
1993,"The helix-loop-helix transcription factor USF (upstream stimulating factor) binds to a regulatory sequence of the human insulin gene enhancer","Read M.L., Clark A.R., Docherty K.",02646021,"Biochemical Journal",295, 1,38,2,3,5,0,43
1993,"How is the developmental timing and tissue-specificity of insulin gene expression controlled?","Clark A.R., Docherty K.",00220795,"Journal of Endocrinology",136, 2,2,0,0,0,0,2
1993,"Cell-specific gene expression in the islets of Langerhans: E boxes and TAAT boxes","Clark A.R., Docherty K.",03005127,"Biochemical Society Transactions",21, 1,2,0,0,0,0,2
1993,"The long-term safety and tolerability of transdermal glyceryl trinitrate, when used with a patch-free interval in patients with stable angina","Wainwright R.J., Foran J.P.M., Padaria S.F., Akhras F., Jackson G., Clark A.R.",00070947,"British Journal of Clinical Practice",47, 4,2,1,0,1,0,3
1993,"The relationship between powder inhaler resistance and peak inspiratory conditions in healthy volunteers - Implications for in vitro testing","Clark A.R., Hollingworth A.M.",08942684,"Journal of Aerosol Medicine: Deposition, Clearance, and Effects in the Lung",6, 2,105,7,4,11,1,117
1991,"Metabolic control of insulin gene expression and biosynthesis.","Docherty K., Clark A.R., Scott V., Knight S.W.",00296651,"Proceedings of the Nutrition Society",50, 3,6,0,0,0,0,6
1991,"Two protein act as the IUF1 insulin gene enhancer binding factor","Scott V., Clark A.R., Hutton J.C., Docherty K.",00145793,"FEBS Letters",290, 1-2,6,1,0,1,0,7
1991,"Lung deposition of 5 mg Intal from a pressurised metered dose inhaler assessed by radiotracer technique","Newman S.P., Clark A.R., Talaee N., Clarke S.W.",03785173,"International Journal of Pharmaceutics",74, 2-3,19,0,1,1,1,21
1990,"Positive and negative regulation of the human insulin gene by multiple trans-acting factors","Boam D.S.W., Clark A.R., Docherty K.",00219258,"Journal of Biological Chemistry",265, 14,61,1,0,1,2,64
1990,"The preparation of a radiolabelled aerosol of nedocromil sodium for administration by metered-dose inhaler that accurately preserves particle size distribution of the drug","Summers Q.A., Clark A.R., Hollingworth A., Fleming Holgate J.S.T.",01142402,"Drug Investigation",2, 2,18,0,0,0,0,18
1990,"The use of reservoir devices for the simultaneous delivery of two metered-dose aerosols","Clark A.R., Rachelefsky G., Mason P.L., Goldenhersh M.J., Hollingworth A.",00916749,"Journal of Allergy and Clinical Immunology",85, 1 I,5,0,0,0,0,5
1989,"A new series of CAT expression vectors","Clark A.R., Boam D.S.W., Docherty K.",03051048,"Nucleic Acids Research",17, 23,11,0,0,0,0,11
1989,"Pressurised aerosol deposition in the human lung with and without an 'open' spacer device","Newman S.P., Clark A.R., Talaee N., Clarke S.W.",00406376,"Thorax",44, 9,65,4,3,7,2,74
